HLTH Executive Series: Investing in the Future of Healthcare with Andrew Adams, OAK HC/FT

About Andrew Adams:

Andrew Adams is the co-founder of Oak HC/FT, established in 2014 to focus exclusively on investing in healthcare and fintech startups. In 2023, the firm was ranked among the top ten venture capital firms globally. With over 25 years of experience, Andrew has been a key investor in numerous high-profile healthcare companies, including One Medical (acquired by Amazon), iHealth Technologies (merged with Connolly), Therapy Brands (acquired by KKR), and PharMEDium Healthcare (acquired by CD&R), among others. He serves on the boards of several healthcare organizations, including August Bioservices, DispatchHealth, and Unified Women's Healthcare. Andrew has been recognized as one of the Top 25 Healthcare Investors of 2024 by GrowthCap. Prior to co-founding Oak HC/FT, he began his career at Alex. Brown & Sons and holds a BA from Princeton University. His extensive track record highlights his deep expertise in healthcare investment and innovation.

Things You’ll Learn:

• Identifying and backing the best entrepreneurs with a strong track record is crucial for achieving impactful scale in healthcare.
• A blend of technology and personalized services is necessary to effectively engage patients and meet their diverse needs.
• Effective patient engagement involves an omnichannel approach, meeting patients where they are, whether virtually, in person, or at home.
• Companies should target specific patient populations with tailored tools, services, and a deep understanding of their needs.
• The future of healthcare investment lies in companies that deliver real value by addressing cost, quality, and the consumer experience across the healthcare continuum.

Resources:

• Connect with and follow Andrew Adams on LinkedIn.
• Discover more about OAK HC/FT on LinkedIn and their website.